To handle ABA research errors allegations corrections retractions and research misconduct concerns, preserve records, protect participants and reporters, describe the allegation without declaring a finding, and route it to the institution or authority named by the governing source. Separate honest error, disputed interpretation, authorship or workplace disputes, possible fabrication, falsification, or plagiarism, and other noncompliance. Correct affected analyses or publications promptly while protecting due process and confidentiality.

Define Hana's governed activity and unit

Integrity response keeps the factual concern, research-record correction, participant protection, employment issue, and formal misconduct process separate but coordinated. Teams asking how to handle ABA research errors allegations corrections retractions and research misconduct concerns need the exact activity, people, purpose, design, data, site, sponsor, funding, institutional scope, authority, current version, participant protections, and unresolved facts before work begins.

Build Hana's research-integrity concern register

Hana records concern, source, allegation wording, affected project and outputs, research support, institution, evidence locations, preservation hold, access, confidentiality, retaliation risk, participant or public risk, immediate correction need, authorship or employment issue, possible regulatory definition, receiving official, inquiry and investigation states, sponsor or journal contacts, response opportunity, findings, appeals, corrections, retractions, data repair, notifications, recovery, prevention, and closure. Every state preserves who decided what and under which source.

Protect participants and ordinary care in Hana's workflow

Hana's thirteen analytic, authorship, record, publication, and conduct concerns must preserve client dignity, ordinary clinical access, voluntary choice, privacy, communication and AAC, authorized decision-making, safety response, equitable treatment, complaints, and freedom from retaliation. A research label, consent signature, payment, supervisor approval, or publication goal cannot expand a role or erase a required protection.

Work through Hana's fictional example

Hana reviews 13 concerns. Twelve have a documented route: five are corrected research-record errors, three are authorship or workplace disputes, two enter the institution's possible-misconduct intake, and two involve other protocol or publication noncompliance. One allegation remains open while the responsible institution is identified. Preserve every proposed, classified, reviewed, approved, exempted, enrolled, changed, reported, published, corrected, held, withdrawn, and closed state with its original version, owner, date, conditions, and validation.

Use Hana's denominator carefully

Routing completion is 12 of 13, or 92.3%. The categories describe routes rather than findings. Inquiry opened, allegation assessed, finding made, publication corrected, participant notified, and prevention validated are later events with separate denominators.

Assign Hana's decisions to authorized owners

Hana preserves facts and routes the concern. The institution's research-integrity officer or other authorized body controls formal inquiry and investigation. Journals and publishers control their records. Clinical, privacy, legal, employment, data, sponsor, and participant-protection owners act within scope.

Address Hana's main interpretation risk

Calling an allegation misconduct before the governing process can harm people and due process. Calling a serious data problem an authorship dispute can also hide threats to participants or the scientific record.

Verify Hana's research control in practice

Hana reconciles original data, analysis versions, contribution records, released outputs, corrections, and institutional notices without attempting an unauthorized investigation. Independent reviewers confirm that public corrections address the actual affected claim.

Place Hana's project inside organizational accountability

Hana's research-integrity concern register uses the CASP Organizational Guidelines public overview only for high-level business, clinical-operations, and risk-management scope in autism service organizations. CASP sells the detailed guidelines. The workflow here is Finni's editorial governance model, not a CASP research protocol, regulatory determination, or institutional approval.

Apply the BACB research duties to Hana's covered roles

Hana's role review uses the current BACB Ethics Code, which applies to BCBA and BCaBA certificants and people who completed an application. Its research section addresses applicable review, participant welfare, informed consent, confidentiality, competence, conflicts, integrity, authorship, publication, and corrections. BACB has no separate organization or corporation jurisdiction, so institutional and legal controls remain necessary.

Anchor Hana's federal scope to the current HHS rule

Hana's federal analysis starts with the HHS 45 CFR 46 page, reviewed in February 2025, which identifies the 2018 Requirements and added subparts for specified populations. Applicability depends on funding, conduct, assurance, institution, activity, and other facts. The page is an authoritative starting point, while the current rule and responsible institution control the determination.

Use the OHRP decision charts as aids for Hana

Hana's reviewer may use the OHRP 2018 Requirements decision charts to organize research, human-subject, exemption, continuing-review, and consent-waiver questions. OHRP calls the charts generalizations and directs users to the full applicable text. They support intake and discussion; they do not authorize an investigator to self-approve a project.

Classify quality improvement carefully for Hana

Hana's project label follows the OHRP Quality Improvement Activities FAQs. OHRP explains that intent to publish is insufficient to decide whether QI is research and that some QI can be nonexempt human-subjects research. Purpose, design, activity, coverage, and an authorized determination matter more than the label chosen by the project team.

Separate HIPAA research permission for Hana

Hana's privacy review uses HHS research guidance under HIPAA, which explains that covered entities may use or disclose PHI for research with individual authorization or through limited rule-defined paths without authorization. Common Rule consent, IRB action, HIPAA authorization or waiver, data-owner approval, and contract terms remain separate decisions even when one document combines information.

Treat informed consent as a process for Hana

Hana's communication plan draws on the OHRP Informed Consent FAQs. OHRP flags that the FAQ predates the 2018 Requirements and 2024 conforming changes, while retaining general nonbinding guidance. Use the current regulation and review decision. The FAQ describes prospective, legally effective, voluntary information exchange with questions and a real choice to join, continue, or withdraw.

Apply child-research requirements precisely for Hana

Hana's child-participant route uses current 45 CFR 46 Subpart D, amended in October 2024. The IRB determines adequate provisions for parental or guardian permission and for child assent when the child is capable, subject to the rule's conditions and possible waivers. Clinical assent policies and research assent determinations should be recorded separately.

Distinguish adverse events and unanticipated problems for Hana

Hana's incident logic uses OHRP guidance on unanticipated problems and adverse events. The guidance explains that only a subset of adverse events are unanticipated problems and describes unexpectedness, relation or possible relation, and increased risk as the three-part analysis. Use the current protocol, institution, and rules for actual reporting decisions and deadlines.

Scope research-misconduct handling for Hana

Hana's integrity route recognizes the 2024 final rule revising 42 CFR Part 93. The rule became effective January 1, 2025, and its regulatory requirements apply beginning January 1, 2026, to covered Public Health Service research-misconduct matters. Allegations received before that applicability date generally follow the 2005 rule unless the institution and respondent elect the new rule in writing. The current rule addresses fabrication, falsification, and plagiarism and excludes honest error or differences of opinion. Other sponsors, institutions, journals, employers, and laws can use different processes; preserve allegations as allegations until the authorized process decides them.

Make Hana's participation process accessible

Hana's access plan uses DOJ effective-communication guidance for covered title II or title III entities. The appropriate aid or service depends on the interaction's nature, length, complexity, context, and the person's usual communication method. Apply the actual entity and rule, preserve AAC and authorship, and test consent, recruitment, questions, incident notices, and withdrawal routes in the formats participants use.

Choose Hana's next review trigger

Review after new evidence, retaliation concern, related publication, participant risk, inquiry decision, finding, appeal, journal action, correction failure, or repeated control defect. Record the changed fact, affected people and records, immediate protection, governing source, decision owner, reporting or amendment route, deadlines, communication, and validation result.

Close Hana's record with accountable evidence

Review the research-integrity concern register with Hana, investigators, qualified clinicians, the institution or reviewing body, participant representatives as applicable, and the specialists named in the manifest. Confirm that service, QI, evaluation, research, review, consent, privacy, safety, data, employment, authorship, publication, and misconduct routes remain distinct; all conditions are traceable; access is tested; and unresolved work has an accountable endpoint. Keep this page draft and noindex until every required review is complete.

Related resources

Sources